- Home
- SEZL vs BHC Comparison
SEZL vs BHC Comparison
Compare SEZL & BHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SEZL
- BHC
- Stock Information
- Founded
- SEZL 2016
- BHC N/A
- Country
- SEZL United States
- BHC Canada
- Employees
- SEZL N/A
- BHC N/A
- Industry
- SEZL Diversified Financial Services
- BHC Biotechnology: Pharmaceutical Preparations
- Sector
- SEZL Finance
- BHC Health Care
- Exchange
- SEZL Nasdaq
- BHC Nasdaq
- Market Cap
- SEZL 1.8B
- BHC 2.0B
- IPO Year
- SEZL N/A
- BHC N/A
- Fundamental
- Price
- SEZL $74.98
- BHC $4.71
- Analyst Decision
- SEZL Strong Buy
- BHC Hold
- Analyst Count
- SEZL 2
- BHC 5
- Target Price
- SEZL $61.42
- BHC $7.20
- AVG Volume (30 Days)
- SEZL 1.0M
- BHC 2.7M
- Earning Date
- SEZL 05-07-2025
- BHC 04-30-2025
- Dividend Yield
- SEZL N/A
- BHC N/A
- EPS Growth
- SEZL 670.52
- BHC N/A
- EPS
- SEZL 2.97
- BHC N/A
- Revenue
- SEZL $329,060,890.00
- BHC $9,731,000,000.00
- Revenue This Year
- SEZL $33.01
- BHC $4.92
- Revenue Next Year
- SEZL $16.24
- BHC $2.36
- P/E Ratio
- SEZL $25.26
- BHC N/A
- Revenue Growth
- SEZL 91.69
- BHC 8.53
- 52 Week Low
- SEZL $10.46
- BHC $3.96
- 52 Week High
- SEZL $81.83
- BHC $9.85
- Technical
- Relative Strength Index (RSI)
- SEZL 80.09
- BHC 36.86
- Support Level
- SEZL $51.77
- BHC $4.63
- Resistance Level
- SEZL $56.91
- BHC $5.60
- Average True Range (ATR)
- SEZL 4.56
- BHC 0.27
- MACD
- SEZL 2.10
- BHC 0.01
- Stochastic Oscillator
- SEZL 84.51
- BHC 11.88
About SEZL Sezzle Inc.
Sezzle Inc is a financing institution that offers technology-driven payment platform. It allows customers to split their purchase into four installments and pay over 6 weeks with only the first payment due at the time of purchase. Companies operations comprise one reportable segment, primarily deriving revenue from payment processing platform in North America.
About BHC Bausch Health Companies Inc.
Bausch Health Companies Inc is a world-wide specialty pharmaceutical, consumer health, and medical device company with a focus on branded products for the gastroenterology, hepatology, neurology and dermatology markets. The company reports revenue in five segments: Salix; International; Solta Medical; Diversified Products and Bausch + Lomb. It generates maximum revenue from the Bausch + Lomb segment.